There was a time when academia viewed industry simply as a cash cow; today, it's all about sharing common goals and mutual respect for cultural differences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooke, R. Dr. Folkman's War, Angiogenesis and the Struggle to Defeat Cancer (Random House, New York, 2001).
Culliton, B. Harvard and Monsanto: the $23-Million Alliance. Science 195, 759–763 (1977).
Kenney, M. The University and the Corporation (Yale University Press, New Haven, 1988).
German Federal Ministry of Research and Education. “Bioeconomy: new concepts for the use of natural products.” http://www.bmbf.de/en/1024.php
Prinz, F. et al. Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712 (2011).
Swinney, D.C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507–519 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schachter, B. Partnering with the professor. Nat Biotechnol 30, 944–952 (2012). https://doi.org/10.1038/nbt.2385
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2385
This article is cited by
-
Raising financing through strategic timing
Nature Nanotechnology (2017)
-
Academia and industry: Companies on campus
Nature (2014)
-
Building a New Biomedical Ecosystem: Pfizer’s Centers for Therapeutic Innovation
Clinical Pharmacology & Therapeutics (2013)
